November 8, 2020
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.
“We congratulate President-elect Joe Biden and Vice President-elect Kamala Harris on their historic victory and look forward to working with the new administration at this pivotal moment for our country. There are many challenges that our nation faces, none more immediate than the continuing COVID-19 public health crisis. As the transition begins, we are presented with an important opportunity to further enhance the public and private collaboration that is so critical to our nation’s ability to effectively respond to COVID-19 and to ensure patients have access to new treatments, including vaccines, once approved.
“HDA is ready to partner with President-elect Biden and Vice President-elect Harris, and both parties in Congress, to leverage the logistics expertise of pharmaceutical distributors, advocate for policies that support a strong and resilient supply chain in response to COVID-19 and beyond, while also continuing to apply the innovations and supply chain efficiencies created by our members that meaningfully impact healthcare affordability and access.”
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.